{
    "2018-09-14": [
        [
            {
                "time": "2018-09-01",
                "original_text": "Wall Street Analysts Are Mostly Positive on Merck in September",
                "features": {
                    "keywords": [
                        "Merck",
                        "positive",
                        "analysts"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-09-01",
                "original_text": "Pacira Shares Look Expensive, Stifel Says In Bearish Initiation",
                "features": {
                    "keywords": [
                        "Pacira",
                        "expensive",
                        "bearish",
                        "Stifel"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-09-01",
                "original_text": "Pharma/Biotech Stocks to Watch This Prostate Cancer Month",
                "features": {
                    "keywords": [
                        "Pharma",
                        "Biotech",
                        "Prostate Cancer"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals",
                        "biotech"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-09-01",
                "original_text": "Pharma Stock Roundup: AZN's Leukemia Drug Wins FDA Nod, MRK's Keytruda in Focus",
                "features": {
                    "keywords": [
                        "AZN",
                        "Leukemia",
                        "FDA",
                        "MRK",
                        "Keytruda"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-09-01",
                "original_text": "Johnson & Johnsonâ€™s Recent Development in HIV",
                "features": {
                    "keywords": [
                        "Johnson & Johnson",
                        "HIV",
                        "development"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-09-01",
                "original_text": "5 Dow Jones Stocks That Are Gaining New Ground",
                "features": {
                    "keywords": [
                        "Dow Jones",
                        "gaining",
                        "new ground"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "general market"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-09-01",
                "original_text": "Johnson & Johnson Expands Blood Cancer Portfolio with Approval",
                "features": {
                    "keywords": [
                        "Johnson & Johnson",
                        "Blood Cancer",
                        "approval"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-09-01",
                "original_text": "Johnson & Johnson To Present At Morgan Stanley Conference; Webcast At 9:55 AM ET",
                "features": {
                    "keywords": [
                        "Johnson & Johnson",
                        "Morgan Stanley",
                        "conference",
                        "webcast"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            }
        ]
    ]
}